Abstract
Rationale: Patients with intestinal failure (IF) type 2 and 3 on fat-free parenteral nutrition (PN) or with a functional short bowel (FSB), are at risk for developing essential fatty acid deficiency (EFAD). This study aims to describe period prevalence of EFAD and essential fatty acid status of patients with IF type 2 and 3.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
